Azusapharma Sciences, Inc.
Records under this name other than patents Azusapharma Sciences, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Azusapharma Sciences, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,021,653 | Shuttle vector for Bifidobacterium and Escherichia coli Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,470,311 | Therapeutic agent for anaerobic diseases Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,734,779 | 5-fluorouracil-resistant bacteria and method for production thereof Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,911,721 | Method of constructing gene transport support Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,228,191 | Transfection vector Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,535,939 | Transfection vector Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,443,061 | Heterologous polypeptide expression cassette Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,563,208 | Co-expression plasmid Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,730,968 | Therapeutic agent for ischemic diseases Lapsed on the fee record Ended Aug 15, 2025 · From the USPTO record | Lapsed on the fee record | Ended Aug 15, 2025 | From the USPTO record |
| US 10,993,972 | Therapeutic agent for ischemic diseases Lapsed on the fee record Ended May 4, 2025 · From the USPTO record | Lapsed on the fee record | Ended May 4, 2025 | From the USPTO record |